abt 491 has been researched along with dihydrotestosterone in 1 studies
| Studies (abt 491) | Trials (abt 491) | Recent Studies (post-2010) (abt 491) | Studies (dihydrotestosterone) | Trials (dihydrotestosterone) | Recent Studies (post-2010) (dihydrotestosterone) |
|---|---|---|---|---|---|
| 9 | 0 | 5 | 9,325 | 307 | 1,517 |
| Protein | Taxonomy | abt 491 (IC50) | dihydrotestosterone (IC50) |
|---|---|---|---|
| Plasma kallikrein | Homo sapiens (human) | 0.0031 | |
| Glucocorticoid receptor | Homo sapiens (human) | 0.54 | |
| Sex hormone-binding globulin | Homo sapiens (human) | 0.0038 | |
| Progesterone receptor | Oryctolagus cuniculus (rabbit) | 0.44 | |
| Progesterone receptor | Homo sapiens (human) | 7.3 | |
| Mineralocorticoid receptor | Homo sapiens (human) | 0.36 | |
| Sex hormone-binding globulin | Rattus norvegicus (Norway rat) | 0.023 | |
| Androgen receptor | Homo sapiens (human) | 0.0048 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.4041 | |
| Androgen receptor | Mus musculus (house mouse) | 0.001 | |
| Mineralocorticoid receptor | Rattus norvegicus (Norway rat) | 2.1 | |
| Testosterone 17-beta-dehydrogenase 3 | Homo sapiens (human) | 0.0026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, L; He, M; Ni, X; Sun, Y; Tang, G; Wang, L; Xu, B; Yu, Y | 1 |
1 other study(ies) available for abt 491 and dihydrotestosterone
| Article | Year |
|---|---|
Effects of platelet-activating factor and its differential regulation by androgens and steroid hormones in prostate cancers.
Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Androgen Receptor Antagonists; Androgens; beta Catenin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclofenil; Dihydrotestosterone; Disease Progression; Estradiol; Hormone Antagonists; Humans; Imidazoles; Indoles; Male; Mifepristone; Platelet Activating Factor; Prostatic Neoplasms; Protein Kinase Inhibitors; RNA Interference; RNA, Small Interfering; Wnt Proteins | 2013 |